Altre lingue Zhejiang Jolly Pharmaceutical Co.,LTD

Azioni

300181

CNE100001096

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 18/06/2024			Variaz. 5gg	Var. 1 gen.
15,88 ^CNY	-0,13%		+1,47%	+48,97%

13/05	Zhejiang Jolly Pharmaceutical Co.,LTD annuncia cambiamenti di amministratore	CI
18/04	Zhejiang Jolly Pharmaceutical Co.,LTD riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Zhejiang Jolly Pharmaceutical Co.,LTD Announces Director Changes	13/05
Zhejiang Jolly Pharmaceutical Co.,LTD Declares Dividend for the Year 2023	13/05
Zhejiang Jolly Pharmaceutical Co.,LTD announced that it has received CNY 909.999997 million in funding	19/04
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	18/04
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	22/10/23
Zhejiang Jolly Pharmaceutical Co.,LTD(XSEC:300181) added to S&P Global BMI Index	18/09/23
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023	08/08/23
Zhejiang Jolly Pharmaceutical Co.,LTD Announces Cash Dividend on A Shares for the Year 2022, Payable on 30 May 2023	24/05/23
Zhejiang Jolly Pharmaceutical Co.,LTD Approves Cash Dividend for 2022	22/05/23
Zhejiang Jolly Pharmaceutical Co.,LTD Proposes Final Cash Dividend for the Year 2022	26/04/23
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Zhejiang Jolly Pharmaceutical Co.,LTD signed an equity transfer agreement to acquire the remaining 48.99% stake in Zhejiang Jolly Baicao Chinese Medicine Decoction Pieces Co., Ltd. from Chen Huan and Chen Zhaorong for RMB 75 million.	15/08/22
Zhejiang Jolly Pharmaceutical Co.,LTD Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 31 May 2022	25/05/22
Zhejiang Jolly Pharmaceutical Co.,LTD completed the acquisition of 8% stake in Zhejiang Top Medicine Co.,Ltd. from Yu Yin.	17/05/22
Zhejiang Jolly Pharmaceutical Co.,Ltd Approves Cash Dividend for 2021	13/05/22
Zhejiang Jolly Pharmaceutical Co.,LTD Proposes Cash Dividend for 2021	20/04/22
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2022	19/04/22
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Full Year Ended December 31, 2021	09/03/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Zhejiang Jolly Pharmaceutical Co.,LTD

Azioni

300181

CNE100001096

Altre lingue

Filtri